Chemoenzymatic Synthesis of Both Enantiomers
silica gel column chromatography (200 g). Elution with
hexane-EtOAc (10:1) afforded 3a (yield: 3.40 g, 41%) and
3b (yield: 5.30 g, 55%). HPLC analysis of 3a: tR (min)=13.9
[(2R,1’S)-, 3.4%], 14.9 [(2S,1’S)-, 96.6%]. HPLC analysis of
3a originating from the recovered acetate: tR (min)=13.2
[(2R,1’R)-, 1.2%], 13.9 [(2R,1’S)-, 86.7%], 14.9 [(2S,1’S)-,
8.8%], 20.8 [(2S,1’R)-, 3.3%].
Repetition of the above-mentioned lipase-catalyzed trans-
esterification was carried out for further kinetic resolution,
as follows. The recovered acetate 3b (5.30 g) in the first res-
olution was treated with C. antarctica lipase B (11 g) in cy-
clopentanol (80 mL) in the same manner. The work-up and
purification gave 3b as recovery (yield: 4.60 g, 88%), whose
stereochemical profile was analyzed after derivation to 3a:
tR (min)=13.2 [(2R,1’R)-, 1.5%], 13.9 [(2R,1’S)-, 93.7%],
14.9 [(2S,1’S)-, 2.1%], 20.8 [(2S,1’R)-, 2.6%].
(2R,1’S)-3a; yield: 587 mg (59% over 2 steps). HPLC: tR
(min)=13.9 [(2R,1’S)-, 99.6%], 20.8 [(2S,1’R)-, 0.4%].
(R)-TBMB Acid (1a)
In a similar manner as for (S)-1a, (R)-TBMB acid (1a) was
obtained as a colorless solid; yield: 122 mg, (73% over two
steps, 99.2% ee). HPLC analysis after derivatizion to (R)-
1b: tR (min)=10.4 [(S)-, 0.4%], 13.1 [(R)-, 99.6%]. Analyti-
cal sample for (R)-1a: mp 171–1728C; [a]2D5: À35.0 (c 1.00,
MeOH). IR, NMR and mass spectra were in good accord-
ance with those of (S)-1a.
Acknowledgements
On the other hand, the alcohol 3a obtained in the first
resolution was acetylated to give 3b (yield: 3.70 g, 95%).
This was treated with C. antarctica lipase B (7.5 g) in cyclo-
pentanol (50 mL) in the same manner. The work-up and pu-
rification gave 3a (yield: 1.90 g, 60%). HPLC: tR (min)=
14.9 [(2S,1’S)-3a, single peak].
The authors thank Professor Kaoru Nakamura of the Insti-
tute for Chemical Research University of Kyoto, Dr. Mikio
Fujii of Toho University and Professor Tohru Yamada of
Keio University, for their valuable discussion and encourage-
ment of this study, and Mr. Yusaku Iwanagaꢀs contribution in
the early phase of this work. Amano Enzyme Inc. for gener-
ous gift of PS-IM, Novozymes Japan for Novozym 435, Su-
mitomo Chemical Co., for B. cepacia lipase and Nagase &
Co., for several proteases and esterase are acknowledged with
thanks. This work was supported both by a Grant-in-Aid for
Scientific Research (No. 18580106) and formation of a re-
search centre in cell signaling drug discovery for molecular
targeting therapies: matching fund subsidy 2009–2013 from
the Ministry of Education, Culture, Sports, Science and Tech-
nology, Japan, which are acknowledged with thanks.
(S)-TBMB Acid (1a)
To a solution of (2S,1’S)-3a (602 mg, 2.08 mmol) in EtOAc
(2.0 mL) was added IBX (1.2 g, 4.92 mmol), and the mixture
was stirred at 808C for 24 h. The mixture was filtered with a
pad of Celite and the filtrate was concentrated under
vacuum. The residue was dissolved in DMF (4.0 mL) and
aqueous NaOH solution (8M, 2.0 mL, 16.0 mmol) added.
The mixture was stirred at room temperature for 1 h and
was then carefully acidified with hydrochloric acid (2M) to
pH 3.5. The precipitated solids were collected by filtration
to give (S)-1a (yield: 424 mg, 87%) as a colorless solid,
whose ee was >99.9% by the HPLC analysis of 1b obtained
by treatment with TMSCHN2: tR (min)=10.4 [(S)-, single
peak]. Recrystallization of (S)-1a from acetone-water af-
forded an analytical sample; mp 171–1728C; [a]2D5: +35.6 (c
1.00, MeOH) {lit.[1] [a]2D2: +30.5 (c 0.1, MeOH)}. Its
1H NMR spectrum was identical with that reported previ-
ously.[1]
References
[1] a) Y. Nishida, H. Ohrui, H. Meguro, Tetrahedron Lett.
1989, 30, 5277–5280; b) Y. Nishida, H. Ohrui, H.
Meguro, C. Kabuto, Anal. Sci. 1991, 7, 349–350; c) Y.
Nishida, M. Abe, H. Ohrui, H. Meguro, Tetrahedron:
Asymmetry 1993, 4, 1431–1434; d) Y. Nishida, E. Itoh,
M. Abe, H. Ohrui, H. Meguro, Anal. Sci. 1995, 11,
213–220.
ACHTUNGTRENNUNG(2R,1’S)-1’-(2-tert-Butyl-2-methyl-1,3-benzodioxol-4-
yl)-2’2’2’-trifluoroethyl Chloroacetate (3c)
[2] C.-S. Chen, Y. Fujimoto, G. Girdaukas, C. J. Sih, J. Am.
Chem. Soc. 1982, 104, 7294–7299.
[3] I. Fatakopoulou, E. Barbayianni, V. Constantinou-Ko-
kodou, U. T. Bornscheuer, G. Kokotos, J. Org. Chem.
2007, 72, 782–786.
The mixture of (2R,1’S)-3a (1.0 g, 3.45 mmol, 95.6% de,
94.6% ee), chloroacetic anhydride (590 mg, 3.45 mmol), pyr-
idine (10 mL), and a catalytic amount of DMAP was stirred
at room temperature for 20 min. The same work-up for 3b
provided chloroacetate 3c as a colorless oil; yield: 1.1 g. This
was employed for the next step without further purification.
[4] R. J. Crawford, W. F. Erman, C. D. Broaddus, J. Am.
Chem. Soc. 1972, 94, 4298–4396.
[5] L. S. Chen, G. J. Chen, C. Tamborski, J. Fluorine Chem.
1981, 18, 117–129.
[6] K. Kato, Y. Gong, R. Irimescu, T. Saito, Y. Yokogawa,
B. cepacia Lipase-Catalyzed Transesterification of
(2R,1’S)-3c
Biotechnol. Lett. 2002, 24, 1623–1630.
[7] K. Kitsuda, J. Calveras, Y. Nagai, T. Higashi, T. Sugai,
J. Mol. Catal. B: Enz. 2009, 59, 197–200.
To a solution of (2R,1’S)-3c (1.10 g, 3.29 mmol, 95.6% de,
94.6% ee) in cyclopentanol (16.0 mL) was added B. cepacia
lipase (Amano PS-IM, 2.2 g). The mixture was stirred for 3
days at 508C. The mixture was filtered with a pad of Celite
and the filtrate was concentrated under vacuum. The residue
was purified by silica gel column chromatography (30 g).
Elution with hexane-EtOAc (50:1 to 10:1) afforded
[8] I. Ohtani, T. Kusumi, Y. Kashman, H. Kakisawa, J.
Am. Chem. Soc. 1991, 113, 4092–4096.
[9] T. Yamada, T. Nagata, Y. Ohtsuka, T. Ikeno, T. Mu-
kaiyama, J. Synth. Org. Chem. Jpn. 2003, 61, 843–856.
[10] a) K. Nakamura, K. Takenaka, M. Fujii, Y. Ida, Tetra-
hedron Lett. 2002, 43, 3629–3631; b) T. Harada, Y.
Adv. Synth. Catal. 2010, 352, 2549 – 2558
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2557